LifeStance Health Group, Inc. (LFST) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 403.48M | 382.19M | 363.81M | 345.31M | 332.97M | 325.48M | 312.72M | 312.33M | 300.44M | 280.6M | 262.89M | 259.58M |
| Revenue Growth % | 21.17% | 17.42% | 16.34% | 10.56% | 10.83% | 15.99% | 18.95% | 20.32% | 18.94% | 22.34% | 20.84% | 23.89% |
| Cost of Goods Sold | 280.86M | 269.33M | 247.23M | 250.89M | 223.18M | 216.04M | 212.29M | 214.53M | 205.71M | 197.29M | 186.69M | 186.61M |
| COGS % of Revenue | 69.61% | 70.47% | 67.96% | 72.66% | 67.03% | 66.38% | 67.88% | 68.69% | 68.47% | 70.31% | 71.01% | 71.89% |
| Gross Profit | 122.61M | 112.86M | 116.58M | 94.42M | 109.79M | 109.44M | 100.43M | 97.81M | 94.73M | 83.31M | 76.21M | 72.97M |
| Gross Margin % | 30.39% | 29.53% | 32.04% | 27.34% | 32.97% | 33.62% | 32.12% | 31.31% | 31.53% | 29.69% | 28.99% | 28.11% |
| Gross Profit Growth % | 11.68% | 3.13% | 16.08% | -3.46% | 15.9% | 31.35% | 31.78% | 34.03% | 36.1% | 32.89% | 26.4% | 21.96% |
| Operating Expenses | 100.24M | 94.41M | 109.17M | 97.38M | 108.19M | 108.38M | 100.38M | 113.75M | 111.5M | 115.58M | 150.57M | 121.38M |
| OpEx % of Revenue | 24.85% | 24.7% | 30.01% | 28.2% | 32.49% | 33.3% | 32.1% | 36.42% | 37.11% | 41.19% | 57.27% | 46.76% |
| Selling, General & Admin | 100.33M | 94.7M | 95.69M | 97.38M | 94.43M | 93.71M | 85.27M | 95.15M | 88.93M | 93.37M | 130.94M | 101.85M |
| SG&A % of Revenue | 24.87% | 24.78% | 26.3% | 28.2% | 28.36% | 28.79% | 27.27% | 30.47% | 29.6% | 33.27% | 49.81% | 39.24% |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | -86K | 0 | 1000K | 0 | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Operating Income | 22.37M | 18.45M | 7.41M | -2.95M | 1.6M | 1.06M | 47K | -15.95M | -16.77M | -32.27M | -74.36M | -48.41M |
| Operating Margin % | 5.54% | 4.83% | 2.04% | -0.85% | 0.48% | 0.33% | 0.01% | -5.11% | -5.58% | -11.5% | -28.28% | -18.65% |
| Operating Income Growth % | 1294.64% | 1642.12% | 15665.96% | 81.5% | 109.56% | 103.28% | 100.06% | 67.06% | 50.81% | 29.86% | -91.45% | 19.94% |
| EBITDA | 35.69M | 31.88M | 20.97M | 11.06M | 15.36M | 15.73M | 15.16M | 2.65M | 5.79M | -10.05M | -54.74M | -28.88M |
| EBITDA Margin % | 8.85% | 8.34% | 5.76% | 3.2% | 4.61% | 4.83% | 4.85% | 0.85% | 1.93% | -3.58% | -20.82% | -11.13% |
| EBITDA Growth % | 132.34% | 102.69% | 38.29% | 316.74% | 165.19% | 256.46% | 127.7% | 109.19% | 138.55% | 62.93% | -161.21% | 33.95% |
| D&A (Non-Cash Add-back) | 13.32M | 13.43M | 13.56M | 14.01M | 13.76M | 14.67M | 15.12M | 18.6M | 22.56M | 22.22M | 19.62M | 19.53M |
| EBIT | 22.37M | 18.08M | 7.39M | -3.04M | 1.6M | 520K | 31K | -16.8M | -14.83M | -32.78M | -72.49M | -46.9M |
| Net Interest Income | 1.79M | -2.88M | -2.81M | -2.9M | -3.07M | -9.4M | -5.41M | -5.82M | -5.9M | -5.53M | -5.48M | -5.12M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | -1.79M | 2.88M | 2.81M | 2.9M | 3.07M | 9.4M | 5.41M | 5.82M | 5.9M | 5.53M | 5.48M | 5.12M |
| Other Income/Expense | -2.61M | -3.25M | -2.84M | -2.99M | -3.07M | -9.94M | -5.43M | -6.67M | -3.96M | -6.04M | -3.61M | -3.61M |
| Pretax Income | 19.76M | 15.2M | 4.57M | -5.94M | -1.47M | -8.88M | -5.38M | -22.62M | -20.73M | -38.32M | -77.97M | -52.02M |
| Pretax Margin % | 4.9% | 3.98% | 1.26% | -1.72% | -0.44% | -2.73% | -1.72% | -7.24% | -6.9% | -13.65% | -29.66% | -20.04% |
| Income Tax | 5.52M | 3.54M | 3.5M | -2.15M | -2.18M | -1.76M | 575K | 656K | 363K | 6.64M | -16.39M | -6.54M |
| Effective Tax Rate % | 27.92% | 23.25% | 76.44% | 36.2% | 148.23% | 19.87% | -10.68% | -2.9% | -1.75% | -17.34% | 21.02% | 12.58% |
| Net Income | 14.24M | 11.67M | 1.08M | -3.79M | 709K | -7.11M | -5.96M | -23.28M | -21.1M | -44.96M | -61.58M | -45.48M |
| Net Margin % | 3.53% | 3.05% | 0.3% | -1.1% | 0.21% | -2.19% | -1.9% | -7.45% | -7.02% | -16.02% | -23.42% | -17.52% |
| Net Income Growth % | 1908.89% | 264.06% | 118.08% | 83.71% | 103.36% | 84.18% | 90.33% | 48.82% | 38.39% | 3.64% | -62.69% | 33.83% |
| Net Income (Continuing) | 14.24M | 11.67M | 1.08M | -3.79M | 709K | -7.11M | -5.96M | -23.28M | -21.1M | -44.96M | -61.58M | -45.48M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 0.04 | 0.03 | 0.00 | -0.01 | 0.00 | -0.02 | -0.02 | -0.06 | -0.06 | -0.12 | -0.17 | -0.13 |
| EPS Growth % | - | 235.48% | 117.83% | 84.01% | 103.21% | 84.5% | 90.76% | 52.85% | 40.89% | 0% | -54.55% | 31.58% |
| EPS (Basic) | 0.04 | 0.03 | 0.00 | -0.01 | 0.00 | -0.02 | -0.02 | -0.06 | -0.06 | -0.12 | -0.17 | -0.13 |
| Diluted Shares Outstanding | 395.08M | 391.14M | 388.89M | 385.01M | 390.67M | 382.74M | 378.71M | 379.43M | 376.33M | 378.73M | 372.48M | 363.16M |
| Basic Shares Outstanding | 387.26M | 386.02M | 386.96M | 385.01M | 383.27M | 382.74M | 378.71M | 379.43M | 376.33M | 378.73M | 372.48M | 363.16M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |